Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Progress in Molecular Biology and Translational Science|October 26, 2024
Magnetic nanoparticles: An emerging nanomedicine for cancer immunotherapyPhoomipat Jungcharoen, Jutatip Panaampon, Thanit Imemkamon, et al.
Oncology Research|December 22, 2025
Molecular Mechanisms of Gemcitabine Resistance in CholangiocarcinomaSonexai Kidoikhammouan, Charupong Saengboonmee, Sopit Wongkham, et al.
Cancer Epidemiology|April 26, 2015
Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma: Association of diabetes mellitus and cholangiocarcinomaCharupong Saengboonmee, Wunchana Seubwai, Chaisiri Wongkham, et al.
Anticancer Research|March 28, 2025
Activation of the γ-Aminobutyric Acid Receptor Type B Suppresses the Proliferation of Lung Adenocarcinoma CellsYubin Zhou, Kullanat Khawkhiaw, Kanyarat Thithuan, et al.
World Journal of Gastrointestinal Oncology|May 20, 2024
Interleukin-1β: Friend or foe for gastrointestinal cancersKullanat Khawkhiaw, Jutatip Panaampon, Thanit Imemkamon, et al.
Canadian Journal of Diabetes|November 21, 2020
Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic MedicationCharupong Saengboonmee, Wunchana Seubwai, Worachart Lert-Itthiporn, et al.
Plos One|May 17, 2024
Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysisTin May Aung, Chetta Ngamjarus, Tanakorn Proungvitaya, et al.
Nutrition and Cancer|August 6, 2021
High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes MellitusCharupong Saengboonmee, Marutpong Detarya, Sakkarn Sangkhamanon, et al.
Anticancer Research|December 25, 2016
Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸBCharupong Saengboonmee, Wunchana Seubwai, Ubon Cha'on, et al.
In Vivo (Athens, Greece)|August 26, 2024
Anti-Tumor and Chemosensitizing Effects of the CDK Inhibitor Dinaciclib on Cholangiocarcinoma In Vitro and In VivoPrin Sungwan, Sonexai Kidoikhammouan, Unchalee Thonsri, et al.
Pageof 6